Angie Drakulich
This is the bio for Angie Drakulich, managing editor of Pharmaceutical Technology magazine.
Angie Drakulich
Editorial Director
732.346.3038, adrakulich@advanstar.com
Angie Drakulich joined Pharmaceutical Technology in 2007, and served as Managing Editor between 2007 and 2011 before becoming Editorial Director. She previously worked at the United Nations Association of the USA as Managing Editor and Assistant Communications Director. Angie has worked an editor, writer, and researcher for Grunar & Jahr USA, Time Inc., and Rodale publishing. She holds a Master of Arts from Seton Hall University’s John C. Whitehead School of Diplomacy and International Relations and a bachelor’s degree from James Madison University.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
